drugset / Trial / NCT02741219

A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section

NCT02741219

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this multicenter study is to evaluate the effectiveness and safety of dexmedetomidine combined with sufentanil for patient-controlled analgesia after caesarean section

Timeline

Start
2015-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 300 ug Intravenous
Comparator Sufentanil Other / unclassified 100 ug Intravenous

Indications

No indication recorded.